Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Deccan Health Care Ltd.

Deccan Health Care

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
13 07 2021 Audited Results & Inter alia, to consider and approve meeting of the Board of Directors of the Company isscheduled to be held on Tuesday, the 13th July, 2021 at 4.00 P.M., to consider inter-alia1. 1. the Audited Financial Results of the Company for the quarter and financial year ended the 31° March, 2021 and any other business with the permission of the chair through Video Conferencing mode.
19 10 2021 Preferential Issue of shares
25 10 2021 Preferential Issue of shares (Revised) TheBoard Meeting to be held on 19/10/2021 has been revised to 25/10/2021 Inter alia, to consider and approve the proposal to issue Equity shares on Preferential basis to Promoters and non-promoters, consider and approve migration of the company from BSE SME Segment to Main Board of BSE India and consider convening an Extraordinary general meeting/postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal of fund raising and migration, we hereby inform you that the meeting of Board of Directors of the company has been postponed due to unavoidable circumstances and rescheduled on October 25, 2021.
13 11 2021 Quarterly Results
09 04 2022 Preferential Issue of shares & Inter alia, to consider and discuss the following matters: 1. To consider and approve the Increase in Authorised Share Capital of the Company; 2. To consider and approve the Related Party Transaction 3. To consider and approve the Migration to Main Board on Voluntary Basis; and 4. To consider and approve the proposal to issue securities on preferential basis to the potential investors and Promoter on Cash and Non-cash basis respectively
29 04 2022 Preferential Issue of shares Inter-alia, to consider and approve the proposal for raising of funds by way of private placement / preferential issue of one or more instruments including equity shares, convertible securities of any description or warrants or debt securities, through preferential issue, private placements, rights issue or any other methods or combination thereof as maybe permitted under applicable laws, subject to such regulatory / statutory approvals as maybe required, including the approval of shareholders of the Company
30 05 2022 Half Yearly Results
13 06 2022 Preferential Issue of shares(Cancelled)
14 11 2022 Half Yearly Results
07 12 2022 Inter alia, to consider and approve :- 1. Migration to the main board of Bombay Stock Exchange and related matters thereto; 2. Any other business with the permission of the chair.
07 02 2023 Inter alia, to consider and approve :- 1 To Approve the Notice of Postal Ballot for passing of Proposed Resolution for migration to the main Board. 2 To Decide the Cut-Off Date for determining eligible Shareholders entitled to vote by Postal Ballot & E-Voting and calendar of event determining various dates for Postal Ballot Process. 3 To Appoint Monika Bhatia, M/s M R Bhatia & Co, Scrutinizer for Conducting of Postal Ballot Procedure. 4 To take the approval of Board for Appointment of National Securities Depository Limited (NSDL) as E-Voting Agency for providing E-Voting facility to members for Postal Ballot Process. 5 Any other Matter with the Permission of the Chair.
13 03 2023 Inter alia, to consider and approve :- 1. To give authority to file In Principal approval for migration to the main board of BSE with stock exchange and related activities thereof subject to the approval of members. 2. Appointment(s)/Recruitment(s) of Key Managerial Personnel and/or Director(s). 3. Any other Matter with the Permission of the Chair.
30 05 2023 Audited Results
29 06 2023 Inter alia, to consider and approve the following matters: 1. Appointment of Statutory Auditor of the Company to fill Casual Vacancy till the next General Meeting 2. Appointment of Secretarial Auditor of the company for the F.Y 2023-24. 3. To consider and discuss any other Business with the permission of the Chairman.
14 08 2023 Quarterly Results
28 08 2023 Preferential Issue of shares & Inter alia, to consider:- 1. Raising of funds by way of Issue of Equity Shares /convertible warrants to Promoters / Promoters Group and person(s) other than promoters / Promoter Group on preferential basis, subject to obtaining approval of the shareholders of the Company. 2. Increase in authorized capital (if required) 3. Any other matter incidental and ancillary related to aforesaid above matters. 4. To consider and discuss any other Business with the permission of the Chairman.
12 10 2023 Inter alia, to discuss, consider and approve the following matters: 1. To allot Equity Shares and/or Convertible Warrants on the basis of preferential allotment to Promoter/Persons belong to promoter Group and Person other than Promoters/Promoters Group of the Company. 2. Any other matter incidental and ancillary related to aforesaid above matters. 3. To consider and discuss any other Business with the permission of the Chairman
11 11 2023 Quarterly Results
21 12 2023 Inter alia, to consider and approve:- 1. To Discuss, Deliberate and Approve Potential Opportunities associated in Foreign Market and Incorporating Subsidiaries accordingly, if required and deemed necessary. 2. Appointment(s)/Recruitment(s) of Additional Director(s). 3. To consider and discuss any other business with the permission of the chairman.
06 02 2024 Quarterly Results
11 03 2024 Inter alia, to consider and approve:- 1. Appointment(s)/Recruitment(s) of Additional Director(s). 2. Draft Notice of Postal Ballot. 3. Appointment of Scrutinizer and e-voting agency for the postal ballot process. 4. Any other matter incidental and ancillary related to aforesaid above matters. 5. To consider and discuss any other business with the permission of the chairman.
21 10 2024 Inter alia, to consider and approve:- 1. the allotment of Equity Shares pursuant to conversion of Convertible Warrants to Dr. Minto Purshotam Gupta, Warrant holder and Promoter of the Company. 2. the request of Promoter and Promoter Group of the Company seeking re-classification from the Promoter/Promoter Group Category to Public Category in line of intimation dated 07 Oct 2024. 3. any other business with the permission of the chairman.
14 11 2024 Quarterly Results
21 12 2024 Inter alia, to consider and approve:- 1. To consider and approve the allotment of Equity Shares pursuant to conversion of Convertible Warrants to Krishna Ventures, Warrant holder of the Company (Person Other than the Promoter/Promoter Group). 2. To consider and discuss any other business with the permission of the chairman.
14 02 2025 Quarterly Results
01 04 2025 Inter alia, to consider and approve the following business: 1. To consider and approve the allotment of Equity Shares pursuant to conversion of Convertible Warrants to Krishna Ventures, Warrant holder of the Company (Person Otherthan the Promoter/Promoter Group). 2. To consider and discuss any other business with the permission of the chairman
11 04 2025 Inter alia, to consider and approve:- 1. To consider and approve the allotment of Equity Shares pursuant to conversion of Convertible Warrants to Focal Ventures Private Limited, Warrant holder of the Company (Person Other than the Promoter/Promoter Group). 2. To consider and discuss any other business with the permission of the chairman
29 05 2025 Audited Results
16 06 2025 Inter alia, to consider and approve:- (1) Draft Notice of Extra-Ordinary General Meeting (EGM) and appointment of Scrutinizer and E-Voting Agency
04 07 2025 Inter alia, to consider and approve:- 1. Approval of Appointment of Company Secretary and Compliance Officer 2. Any other matter incidental and ancillary related to aforesaid above matters. 3. To consider and discuss any other business with the permission of the chairman
14 08 2025 Quarterly Results
04 09 2025 Inter alia, to consider and approve:- 1. To approve the Draft Notice of 29th Annual General Meeting. 2. To approve the Draft Director Report for the financial year 2024-25. 3. To fix date and time for conducting 29th Annual General Meeting of the company through video conferencing (VC)/other Audio-Visual Means (OAVM) for the Financial Year ended on 31 March 2025. 4. To fix book closure schedule and E voting schedule for ensuing Annual General Meeting of the company. 5. To consider and approve appointment of E-voting agency and Scrutinizer for e-voting process of AGM. 6. To Reappoint Mr. Ruchi Khattar as Independent Director of the Company as Independent Director For Second Term. 7. To Appoint M/S. M.R.Bhatia & Co., Company Secretaries as a Secretarial Auditor of the Company For 5 Years. 8. To consider and discuss any other business with the permission of the chairma
14 11 2025 Quarterly Results
11 12 2025 Inter alia, to consider and approve:- 1. To consider and approve appointment of Independent Director(s). 2. To consider and discuss any other business with the permission of the chairman.
13 02 2026 Quarterly Results

News

13-JUN-2022

Deccan Health Care raises Rs 4.99 crore from Venture Gurukool Investment Trust

The said equity shares shall be listed on Bombay Stock Exchange

02:58 PM
Enrich money logo